245 results on '"Cooney E"'
Search Results
2. 73 A pilot of introducing Comprehensive Geriatric Assessment (CGA) in older patients admitted to an acute hospital to prevent acute re-hospitalisation
3. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
4. Innovative Physico-Chemical Wastewater Treatment Research Down-Under
5. The SIROFLOC Sewage Treatment Process: A High Rate Process for Sewage Clarification
6. A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1
7. Safety and Immunogenicity of the ChAdox1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 in HIV Infection
8. Supplement to: A randomized trial of nighttime physician staffing in an intensive care unit.
9. Capital Exports, and Investment in Building in Britain and the U.S.A. 1856-1914
10. Long Waves in Building in the British Economy of the Nineteenth Century
11. The Origins of the Victorian Master Builders
12. Daclatasvir combined with peginterferon alfa-2a and ribavirin for 12 or 16 weeks in patients with hepatitis C virus genotype 2 or 3 infection: COMMAND GT2/3 study
13. Performance and Reliability of Thick Cu Interconnects for RF and Analog/Mixed Signal Technology
14. Efficacy and safety of entecavir (ETV) vs. adefovir (ADV) in chronic hepatitis B (CHB) patients with evidence of hepatic decompensation: ETV-048 study
15. Entecavir is well-tolerated for treatment of chronic hepatitis B: phase III safety analysis in nucleoside-naïve and lamivudine-refractory patients: APASL\Abstract\220
16. The Speculative Builders and Developers of Victorian London: A Comment
17. Innovation and Contracts in the Postwar British Building Industry
18. Innovation in the postwar British building industry : a historical view
19. Eighteenth Century Britain's Missing Sawmills: A Blessing in Disguise?
20. Productivity, Conflict and Order in the British Construction Industry: A Historical View
21. 19TH CENTURY BUILDING
22. The organisation of building in England in the 19th century
23. Long Waves in Building in the British Economy of the Nineteenth Century
24. Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin
25. A randomized, placebo‐controlled study of theNS5B inhibitor beclabuvir with peginterferon/ribavirin forHCVgenotype 1
26. Fair and Reasonable. Building Contracts Since 1550. A Synopsis JAMES NISBET
27. O115 PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE
28. The British Building Industry Since 1800. An Economic History. 2nd edition CHRISTOPHER POWELL
29. 739 ALT FLARES DURING TREATMENT WITH PEGINTERFERON LAMBDA OR PEGINTERFERON alfa IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B INFECTION (CHB)
30. 451 EVALUATION OF PHARMACOKINETIC DRUG–DRUG INTERACTION (DDI) BETWEEN BMS-791325, AN NS5B NON-NUCLEOTIDE POLYMERASE INHIBITOR, DACLATASVIR AND ASUNAPREVIR IN TRIPLE COMBINATION IN HCV GENOTYPE 1-INFECTED PATIENTS
31. 1418 DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY
32. Reliability of circuits under pads for Au and Cu wire bonding
33. 1194 CHARACTERIZATION OF VIRAL ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH BMS-791325 AND PEGYLATED INTERFERON-ALFA AND RIBAVIRIN
34. 1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION
35. Interconnect processes and reliability for RF technology
36. Characterization of LTO coating on microlens of CMOS image sensor
37. 1011 RISK AND PREDICTORS OF MORTALITY OR HEPATOCELLULAR CARCINOMA AMONG ENTECAVIR- OR ADEFOVIR-TREATED CHRONIC HEPATITIS B PATIENTS WITH EVIDENCE OF HEPATIC DECOMPENSATION
38. High and low density complimentary MIM capacitors fabricated simultaneously in advanced RFCMOS and BiCMOS technologies
39. 76: Reduced intenity allogeneic stem cell transplantion followed by targeted consolidation immunotherapy with gemtuzumab ozogamicin in children and adolescents with CD33+ acute myeloid leukemia
40. 212: Adenovirus (ADV) infections following allogeneic stem cell transplant (alloSCT) in children and adolescent recepients
41. 3: Reduced Intensity (RI) aLlogeneic Cord Blood Hematopoietic Cell Transplantation (Allo-CBHCT) in Pediatric Patients with Malignant and Non-Malignant Diseases
42. Reduced intensity (RI) allogeneic cord blood hematopoietic cell transplantation (Allo CBHCT) in pediatric patients with malignant and non-malignant diseases
43. P.110 Entecavir is well tolerated for the treatment of nucleoside-naive and lamivudine-refractory chronic hepatitis B: phase II/III safety results
44. Reduced Intensity (RI) Allogeneic Cord Blood Hematopoietic Cell Transplantation (Allo CBHCT) in Pediatric Patients with Malignant and Non-Malignant Diseases.
45. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy
46. A pilot study of myeloablative (MA) autologous stem cell transplantation (AUTOSCT) followed by reduced intensity (RI) allogeneic transplantation (ALLOSCT) in children and young adults with relapsed/refractory lymphoma
47. Interconnect processes and reliability for RF technology.
48. A high performance liner for copper damascene interconnects
49. Integration of copper with low-k dielectrics for 0.13 μm technology.
50. Effects of copper seedlayer deposition method for electroplating
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.